Oregon Health & Science University Knight Cancer Institute researchers uncovered a gene that may be the key to helping kidney cancer patients who don’t respond to current
therapies. This discovery could also provide a toolkit to identify patients who are most likely to benefit from drugs that block this gene from causing cancer cells to grow.
The OHSU study, published in Science Translational Medicine, identified a gene called Src that helps certain kidney cancers grow. Discovering that Src plays a role in kidney cancer could help in delivering more effective, individualized treatments to patients, said George Thomas, M.D., the study’s senior author and a surgical pathologist at the OHSU Knight Cancer Institute.
To read more about the research, visit: http://www.ohsu.edu/xd/about/news_events/news/2011/06-02-kidney-cancer-discovery.cfm